Trial intelligence / Profile preview

Comparative Study of Xalatan vs. Travatan Z on Ocular Surface

NCT00468988Phase 4Completed

Sponsor
Alcon Inc.
Start
May 2007
Primary completion
Jul 2007
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 4 trial of travoprost in primary open-angle glaucoma (POAG), ocular hypertension, pigmentary glaucoma (PG), sponsored by Alcon Inc.. Started May 2007; status: completed.

02

Drugs

travoprost
03

Conditions

primary open-angle glaucoma (POAG)ocular hypertensionpigmentary glaucoma (PG)

Beyond the preview

Go deeper on NCT00468988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00468988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call